tradingkey.logo
๎™ผ
tradingkey.logo
๎™๊ฒ€์ƒ‰
๎™

Monopar Therapeutics Inc

MNPR
๎˜ญ๊ด€์‹ฌ ๋ชฉ๋ก์— ์ถ”๊ฐ€
110.450USD
+0.580+0.53%
์ข…๊ฐ€ย 07-27 16:00๏ผˆET๏ผ‰์‹œ์„ธ๋Š” 15๋ถ„ ์ง€์—ฐ๋ฉ๋‹ˆ๋‹ค
739.91M์‹œ๊ฐ€์ด์•ก
์†์‹คP/E TTM

MNPR ์žฌ๋ฌด ๋ฐ์ดํ„ฐ

์Šค๋งˆํŠธํ•œ ํˆฌ์ž์ž๋ฅผ ์œ„ํ•ด ์„ค๊ณ„๋œ ์˜ฌ์ธ์› ๋ฐ์ดํ„ฐ ๋Œ€์‹œ๋ณด๋“œ๋ฅผ ํ†ตํ•ด Monopar Therapeutics Inc์˜ ์žฌ๋ฌด ๋ฐ์ดํ„ฐ๋ฅผ ํ™•์ธํ•˜์„ธ์š”. ๋ณต์žกํ•œ ์žฌ๋ฌด์ œํ‘œ๋ฅผ ์‚ฌ์šฉ์ž ์ •์˜ ๊ฐ€๋Šฅํ•œ ๋ทฐ๋กœ ๊ตฌ์„ฑํ•˜์—ฌ ์žฌ๋ฌด ๋ถ„์„์„ ์ œ๊ณตํ•ฉ๋‹ˆ๋‹ค. ์ตœ์‹  ์—ฐ๊ฐ„ ์žฌ๋ฌด ๋ณด๊ณ ์„œ์— ์ ‘๊ทผํ•˜๊ฑฐ๋‚˜, ์†์ต๊ณ„์‚ฐ์„œ, ์žฌ๋ฌด์ƒํƒœํ‘œ, ํ˜„๊ธˆ ํ๋ฆ„ํ‘œ๋ฅผ ์‚ฌ์šฉํ•˜์—ฌ ๋ถ„๊ธฐ๋ณ„ ์„ฑ๊ณผ๋ฅผ ๋ถ„์„ํ•˜์„ธ์š”. ์‹ค์‹œ๊ฐ„ ์žฌ๋ฌด ์ง€ํ‘œ๋ฅผ ์†๋์—์„œ ํ™•์ธํ•  ์ˆ˜ ์žˆ์–ด ํšŒ์‚ฌ์˜ ์‹œ์žฅ ๊ฑด์ „์„ฑ์„ ์‹œ๊ฐ„์— ๋”ฐ๋ผ ๊ทธ ์–ด๋А ๋•Œ๋ณด๋‹ค ์‰ฝ๊ฒŒ ๋ชจ๋‹ˆํ„ฐ๋งํ•  ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค.

Monopar Therapeutics Inc ์‹ค์  ๋ฐœํ‘œ์ผ

์ตœ์‹  ์ถœ์‹œ
May 14, 2026
EPS / ์˜ˆ์ƒ
-0.46/-0.84
์ˆ˜์ต / ์˜ˆ์ƒ
--/0.00
์ฃผ๊ธฐ
FY2025 ์žฌ๋ฌด์ œํ‘œ
์ˆ˜์ต(YoY)
--
--
EPS(YoY)
-1.85
54.99%
์• ๋„๋ฆฌ์ŠคํŠธ ํ‰๊ฐ€
BUY
2026/07/27
๋ถ„๊ธฐ๋ณ„๎˜ฎ
๋ถ„๊ธฐ๋ณ„+์—ฐ๊ฐ„
๋ถ„๊ธฐ๋ณ„
์—ฐ๊ฐ„
YOY
๋นˆ ํ–‰ ์ˆจ๊ธฐ๊ธฐ
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
์žฌ๋ฌด ์ง€ํ‘œ
EPS
-21.41%-0.46
72.65%-0.61
-30.25%-0.48
28.41%-0.35
26.85%-0.38
-259.71%-2.23
46.45%-0.37
40.25%-0.49
44.71%-0.51
44.90%-0.62
---0.69
---0.82
---0.93
---1.12
---3.01
----
----
----
----
----
์ˆœ์ด์ต
-48.31%-3.89M
52.40%-5.20M
-163.56%-3.44M
-43.04%-2.45M
-59.94%-2.62M
-502.32%-10.93M
33.24%-1.30M
22.03%-1.72M
32.59%-1.64M
37.37%-1.81M
18.58%-1.95M
20.37%-2.20M
0.90%-2.43M
-8.05%-2.90M
2.39%-2.40M
-32.82%-2.76M
-30.40%-2.46M
-25.94%-2.68M
-49.96%-2.46M
-43.88%-2.08M
์˜์—… ์ด์ต
-62.18%-5.23M
44.42%-6.16M
-159.89%-4.09M
-80.81%-3.23M
-86.95%-3.22M
-479.22%-11.07M
23.77%-1.57M
23.17%-1.79M
31.75%-1.72M
34.33%-1.91M
14.18%-2.07M
15.75%-2.33M
-2.76%-2.53M
-8.60%-2.91M
2.10%-2.41M
-32.07%-2.76M
-29.69%-2.46M
-18.59%-2.68M
-49.21%-2.46M
-42.91%-2.09M
์ˆœ์ด์ต
-48.31%-3.89M
52.40%-5.20M
-163.56%-3.44M
-43.04%-2.45M
-59.94%-2.62M
-502.32%-10.93M
33.24%-1.30M
22.03%-1.72M
32.59%-1.64M
37.37%-1.81M
18.58%-1.95M
20.37%-2.20M
0.90%-2.43M
-8.05%-2.90M
2.39%-2.40M
-32.82%-2.76M
-30.40%-2.46M
-25.94%-2.68M
-49.96%-2.46M
-43.88%-2.08M
์œ ๋™์ž์‚ฐ
150.10%137.74M
132.97%140.46M
2273.95%144.09M
648.60%53.75M
517.98%55.08M
722.24%60.29M
-29.16%6.07M
-30.30%7.18M
-24.36%8.91M
-44.31%7.33M
-40.38%8.57M
-38.14%10.30M
-34.58%11.78M
-35.84%13.17M
-35.98%14.37M
-31.72%16.65M
-30.29%18.01M
22.15%20.52M
24.11%22.45M
91.59%24.39M
์œ ๋™ ๋ถ€์ฑ„ ์ด๊ณ„
64.73%2.46M
-47.94%2.74M
128.75%2.57M
45.36%1.58M
3.96%1.49M
198.98%5.25M
-43.34%1.12M
-56.45%1.09M
-50.30%1.44M
-43.83%1.76M
3.53%1.98M
14.40%2.50M
168.85%2.89M
97.96%3.13M
54.39%1.91M
98.16%2.19M
33.22%1.07M
34.32%1.58M
103.32%1.24M
92.56%1.10M
์ด ์ž์‚ฐ
150.49%137.98M
133.40%140.72M
2275.71%144.20M
650.24%53.87M
518.08%55.09M
720.83%60.29M
-29.37%6.07M
-30.55%7.18M
-24.68%8.91M
-44.47%7.35M
-40.51%8.59M
-38.23%10.34M
-34.51%11.83M
-35.55%13.23M
-35.85%14.45M
-31.57%16.74M
-30.26%18.07M
21.66%20.52M
24.02%22.52M
91.03%24.46M
๋ถ€์ฑ„ ์ด๊ณ„
73.55%2.59M
-44.99%2.89M
135.06%2.64M
52.73%1.66M
3.96%1.49M
198.98%5.25M
-43.34%1.12M
-56.45%1.09M
-50.30%1.44M
-43.98%1.76M
2.41%1.98M
12.69%2.50M
162.65%2.89M
98.50%3.14M
56.07%1.94M
101.16%2.22M
36.36%1.10M
34.32%1.58M
86.61%1.24M
70.28%1.10M
์ž๋ณธ ์ด๊ณ„
152.63%135.39M
150.43%137.83M
2761.61%141.56M
757.13%52.20M
616.76%53.59M
884.95%55.04M
-25.18%4.95M
-22.29%6.09M
-16.41%7.48M
-44.62%5.59M
-47.15%6.61M
-46.02%7.84M
-47.28%8.94M
-46.73%10.09M
-41.21%12.51M
-37.84%14.52M
-32.40%16.97M
20.71%18.94M
21.64%21.28M
92.14%23.35M
์ˆœ์˜์—…์ด์ต
38.66%-3.47M
-68.64%-3.37M
-94.74%-2.09M
35.75%-1.08M
-242.11%-5.66M
-29.27%-2.00M
44.66%-1.07M
20.21%-1.68M
27.11%-1.66M
-18.75%-1.55M
9.71%-1.94M
-60.32%-2.10M
7.96%-2.27M
35.93%-1.30M
-10.67%-2.15M
6.78%-1.31M
-27.32%-2.47M
-63.77%-2.03M
-49.27%-1.94M
-41.25%-1.41M
์ˆœํˆฌ์ž
-1613.65%-5.58M
-333.72%-62.19M
-315.68%-2.13M
49100.99%1.19M
66.86%-325.83K
-582.70%-14.34M
7652.33%985.73K
-100.08%-2.42K
0.01%-983.31K
160.39%2.97M
---13.05K
--2.95M
---983.44K
---4.92M
----
----
----
----
----
----
์ˆœ์žฌ๋ฌดํ™œ๋™
-73.06%-200.20K
-100.69%-384.68K
558897.68%92.39M
-3094.32%-316.85K
-103.64%-115.68K
16679.90%56.14M
-106.70%-16.53K
-101.55%-9.92K
295.36%3.18M
141.14%334.55K
1139.27%246.70K
1079.50%641.18K
4928.98%804.80K
1885.09%138.74K
-137.90%-23.74K
-172.72%-65.46K
-100.15%-16.67K
-8.85%-7.77K
-100.15%-9.98K
-102.54%-24.00K

์ž์ฃผ ๋ฌป๋Š” ์งˆ๋ฌธ

Monopar Therapeutics Inc์˜ ์œ ๋™์ž์‚ฐ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Monopar Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์œ ๋™์ž์‚ฐ์€ 140.46M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 132.97์ž…๋‹ˆ๋‹ค.

Monopar Therapeutics Inc์˜ ์ด์ž์‚ฐ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Monopar Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Monopar Therapeutics Inc์˜ ์ด์ž์‚ฐ์€ 140.72M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 133.40์ž…๋‹ˆ๋‹ค.

Monopar Therapeutics Inc์˜ ์ด๋ถ€์ฑ„๋Š” ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Monopar Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Monopar Therapeutics Inc์˜ ์ด๋ถ€์ฑ„๋Š” 2.89M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -44.99์ž…๋‹ˆ๋‹ค.

Monopar Therapeutics Inc์˜ ์ด์ž๋ณธ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Monopar Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Monopar Therapeutics Inc์˜ ์ด์ž๋ณธ์€ 137.83M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 150.43์ž…๋‹ˆ๋‹ค.

Monopar Therapeutics Inc์˜ ์ˆœ์˜์—…์†Œ๋“์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Monopar Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Monopar Therapeutics Inc์˜ ์ˆœ์˜์—…์†Œ๋“์€ -16.70M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -3.36์ž…๋‹ˆ๋‹ค.

Monopar Therapeutics Inc์˜ ์ˆœํˆฌ์ž๋Š” ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Monopar Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Monopar Therapeutics Inc์˜ ์ˆœํˆฌ์ž๋Š” -63.45M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -342.54์ž…๋‹ˆ๋‹ค.

Monopar Therapeutics Inc์˜ ์ˆœ์ž๊ธˆ์กฐ๋‹ฌ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Monopar Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Monopar Therapeutics Inc์˜ ์ˆœ์ž๊ธˆ์กฐ๋‹ฌ์€ 91.57M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 54.45์ž…๋‹ˆ๋‹ค.

Monopar Therapeutics Inc์˜ ์ฃผ๋‹น์ˆœ์ด์ต(EPS)์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Monopar Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ฃผ๋‹น์ˆœ์ด์ต(EPS)์€ -1.85์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 54.99์ž…๋‹ˆ๋‹ค.

Monopar Therapeutics Inc์˜ ์ˆœ์ด์ต์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Monopar Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ˆœ์ด์ต์€ -13.72M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 11.99์ž…๋‹ˆ๋‹ค.

Monopar Therapeutics Inc์˜ ์ž๊ธฐ์ž๋ณธ์ด์ต๋ฅ (ROE)์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Monopar Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ž๊ธฐ์ž๋ณธ์ด์ต๋ฅ (ROE)์€ -14.22์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 72.34์ž…๋‹ˆ๋‹ค.

Monopar Therapeutics Inc์˜ ์ด์ž์‚ฐ์ด์ต๋ฅ (ROA)์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Monopar Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ด์ž์‚ฐ์ด์ต๋ฅ (ROA)์€ -13.65์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 70.39์ž…๋‹ˆ๋‹ค.

Monopar Therapeutics Inc์˜ ์˜์—…์ด์ต์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Monopar Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์˜์—…์ด์ต์€ -16.70M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -3.36์ž…๋‹ˆ๋‹ค.
tradingkey.logo
์œ„ํ—˜ ๊ฒฝ๊ณ : ์ €ํฌ ์›น์‚ฌ์ดํŠธ์™€ ๋ชจ๋ฐ”์ผ ์•ฑ์€ ํŠน์ • ํˆฌ์ž ์ƒํ’ˆ์— ๋Œ€ํ•œ ์ผ๋ฐ˜์ ์ธ ์ •๋ณด๋งŒ์„ ์ œ๊ณตํ•ฉ๋‹ˆ๋‹ค. Finsights๋Š” ์žฌ์ •์  ์กฐ์–ธ์ด๋‚˜ ํˆฌ์ž ์ƒํ’ˆ์— ๋Œ€ํ•œ ์ถ”์ฒœ์„ ์ œ๊ณตํ•˜์ง€ ์•Š์œผ๋ฉฐ, ์ด๋Ÿฌํ•œ ์ •๋ณด ์ œ๊ณต์ด Finsights๊ฐ€ ๊ธˆ์œต ์กฐ์–ธ์ด๋‚˜ ์ถ”์ฒœ์„ ์ œ๊ณตํ•˜๋Š” ๊ฒƒ์œผ๋กœ ํ•ด์„๋˜์–ด์„œ๋Š” ์•ˆ ๋ฉ๋‹ˆ๋‹ค.
ํˆฌ์ž ์ƒํ’ˆ์€ ํˆฌ์ž ์›๊ธˆ ์†์‹ค์„ ํฌํ•จํ•œ ์ƒ๋‹นํ•œ ํˆฌ์ž ์œ„ํ—˜์— ๋…ธ์ถœ๋˜์–ด ์žˆ์œผ๋ฉฐ, ๋ชจ๋“  ์‚ฌ๋žŒ์—๊ฒŒ ์ ํ•ฉํ•˜์ง€ ์•Š์„ ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค. ํˆฌ์ž ์ƒํ’ˆ์˜ ๊ณผ๊ฑฐ ์„ฑ๊ณผ๋Š” ๋ฏธ๋ž˜ ์„ฑ๊ณผ๋ฅผ ๋ณด์žฅํ•˜์ง€ ์•Š์Šต๋‹ˆ๋‹ค.
Finsights๋Š” ์ œ3์ž ๊ด‘๊ณ ์ฃผ๋‚˜ ์ œํœด์‚ฌ๊ฐ€ ์ €ํฌ ์›น์‚ฌ์ดํŠธ๋‚˜ ๋ชจ๋ฐ”์ผ ์•ฑ ๋˜๋Š” ๊ทธ ์ผ๋ถ€์— ๊ด‘๊ณ ๋ฅผ ๊ฒŒ์žฌํ•˜๊ฑฐ๋‚˜ ์ „๋‹ฌํ•  ์ˆ˜ ์žˆ๋„๋ก ํ—ˆ์šฉํ•  ์ˆ˜ ์žˆ์œผ๋ฉฐ, ์‚ฌ์šฉ์ž๊ฐ€ ๊ด‘๊ณ ์™€ ์ƒํ˜ธ์ž‘์šฉํ•˜๋Š” ๋ฐฉ์‹์— ๋”ฐ๋ผ ์ด๋“ค๋กœ๋ถ€ํ„ฐ ๋ณด์ƒ์„ ๋ฐ›์„ ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค.
ยฉ ์ €์ž‘๊ถŒ: FINSIGHTS MEDIA PTE. LTD. ๋ชจ๋“  ๊ถŒ๋ฆฌ ๋ณด์œ